Medical World News® After Hours: Thoracic Medical Oncologist Inga Lennes, MD, MBA, MPH, on Healthy Eating

Video

During an After Hours segment of Medical World News®, Inga Lennes, MD, MBA, MPH, spoke about her passion for healthy cooking and how it helps her unwind after a busy week of treating patients.

For this installment of After Hours from the Medical World News® broadcast, CancerNetwork® sat down with Inga Lennes, MD, MBA, MPH, to talk about her love of cooking, healthy eating, and her personal Instagram, @IngaKitchen, where she posts photos of her latest recipes.

She says cooking offers her an opportunity to shift gears after a long day at work as well as provide nourishing food for her family, making this a hobby that’s easy to stick to. She also shared some words of wisdom about staying on track with healthy eating and having motivation to cook meals on a busy schedule.

Recent Videos
Experts weigh in on tumor-informed testing, false positives, relevant trial data, and other key concepts related to circulating tumor DNA.
Hydration and a healthy, well-balanced diet may mitigate fatigue among patients undergoing treatment for cancer.
Bland foods, such as crackers and chicken noodle soup, as well as fluids with electrolytes, may help stave off treatment-related nausea.
According to Denise B. Reynolds, RD, patients eating well should not be experiencing nutritional deficiencies during cancer treatment.
Related Content
Black patients experienced lower survival rates across cancer types and several categories of urbanicity, particularly in breast and colorectal cancers.

Five-Year Cancer Survival Rates Lower Among Rural Cancer Populations

Roman Fabbricatore
September 25th 2025
Article

Black patients experienced lower survival rates across cancer types and several categories of urbanicity, particularly in breast and colorectal cancers.

Experts discuss key considerations for applying ctDNA to clinical practice, such as distinguishing between tumor-informed and tumor-uninformed testing.

Diving Into the Practical Applications of ctDNA in Oncology Care

Manojkumar Bupathi, MD, MS;Benjamin Garmezy, MD;Arnab Basu, MBBS, MPH, FACP
September 25th 2025
Podcast

Experts discuss key considerations for applying ctDNA to clinical practice, such as distinguishing between tumor-informed and tumor-uninformed testing.

Greater regulatory and policy clarity may better optimize clinician use of artificial intelligence in treating patients with cancer.

Advancing AI in Oncology: Critical Considerations for Clinical Practice

Roman Fabbricatore
September 19th 2025
Article

Greater regulatory and policy clarity may better optimize clinician use of artificial intelligence in treating patients with cancer.

How to Discuss Death: A Conversation of Mortality in Cancer Care

How to Discuss Death: A Conversation of Mortality in Cancer Care

Daniel C. McFarland, DO;William Breitbart, MD
September 22nd 2025
Podcast

Daniel C. McFarland, DO; and guest William S. Breitbart, MD, discuss the critical role of meaning-centered therapy in addressing the psychosocial needs of patients with cancer.

Clinical benefit with the investigational agent was reported among 48% of patients with solid tumors at or above the therapeutic dose threshold.

LP-184 Shows Favorable Safety, Pharmacokinetics in Advanced Solid Tumors

Roman Fabbricatore
September 17th 2025
Article

Clinical benefit with the investigational agent was reported among 48% of patients with solid tumors at or above the therapeutic dose threshold.

Rezatapopt Yields Responses Across TP53 Y220C-Mutated Solid Tumor Types

Rezatapopt Yields Responses Across TP53 Y220C-Mutated Solid Tumor Types

Tim Cortese
September 10th 2025
Article

Rezatapopt achieved an ORR of 33% in all patients, and an ORR of 43% in patients with ovarian cancer, with 1 confirmed complete response.